Sarcosine → [(5-{1-[4-(1-Hydroxy-1-methyl-ethyl)-2-trifluoromethyl-benzyl]-1H-indazol-5-ylmethylene}-4-oxo-4,5-dihydro-thiazol-2-yl)-methyl-amino]-acetic acid
반응식
C(S[C:4]1[S:5][C:6](=[CH:10][C:11]2[CH:12]=[C:13]3[C:17](=[CH:18][CH:19]=2)[N:16]([CH2:20][C:21]2[CH:26]=[CH:25][C:24]([C:27]([OH:30])([CH3:29])[CH3:28])=[CH:23][C:22]=2[C:31]([F:34])([F:33])[F:32])[N:15]=[CH:14]3)[C:7](=[O:9])[N:8]=1)C.[CH3:35][NH:36][CH2:37][C:38]([OH:40])=[O:39]>>[OH:30][C:27]([C:24]1[CH:25]=[CH:26][C:21]([CH2:20][N:16]2[C:17]3[C:13](=[CH:12][C:11]([CH:10]=[C:6]4[S:5][C:4]([N:36]([CH2:37][C:38]([OH:40])=[O:39])[CH3:35])=[N:8][C:7]4=[O:9])=[CH:19][CH:18]=3)[CH:14]=[N:15]2)=[C:22]([C:31]([F:33])([F:32])[F:34])[CH:23]=1)([CH3:29])[CH3:28]참가 물질
3
반응물 2
생성물 1
실험 절차
[(5-{1-[4-(1-Hydroxy-1-methyl-ethyl)-2-trifluoromethyl-benzyl]-1H-indazol-5-ylmethylene}-4-oxo-4,5-dihydro-thiazol-2-yl)-methyl-amino]-acetic acid was prepared from 2-Ethylsulfanyl-5-{1-[4-(1-hydroxy-1-methyl-ethyl)-2-trifluoromethyl-benzyl]-1H-indazol-5-ylmethylene}-thiazol-4-one and N-Methyl Glycine following General Procedure C.
출처 및 근거
- ORD 기록
- ord-89ef739de7e4494daff4e59a96191bfb
- 출처 데이터셋
- uspto-grants-2013_04
- 특허 번호
- US08426604B2
반응 노트
불러오는 중…